1. 1339PmRNA expression of ER, PR, HER2 and Ki67 are concordant to central ihc and predict clinical outcome: A validation study from the ABCSG-6 biomarker cohort. (23rd October 2018) Authors: Filipits, M; Rudas, M; Singer, C; Bago-Horvath, Z; Greil, R; Balic, M; Lax, S F; Wu, N; Zhao, S; Weidler, J; Bates, M; Hlauschek, D; Gnant, M; Dubsky, P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2OPrognostic value of endopredict for invasive lobular carcinomas in the combined ABCSG-6/8 and TransATAC trials. (13th May 2019) Authors: Sestak, I; Filipits, M; Buus, R; Rudas, M; Knauer, M; Kronenwett, R; Cuzick, J; Gnant, M I; Dowsett, M; Dubsky, P Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 458PMutation tracking in circulating tumour DNA predicts relapse in completely resected EGFR-mutated NSCLC. (24th November 2019) Authors: Filipits, M; Hochmair, M J; Buder, A; Watzka, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 495PTracking of activating EGFR mutations predicts progression-free survival in advanced EGFR-mutated NSCLC patients treated with osimertinib. (24th November 2019) Authors: Buder, A; Hochmair, M J; Setinek, U; Filipits, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis. Issue 4 (2nd September 2004) Authors: Wolf, J; Stranzl, T; Filipits, M; Pohl, G; Pirker, R; Leeb, B; Smolen, J S Journal: Annals of the rheumatic diseases Issue: Volume 64:Issue 4(2005) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HCRP1 expression status is a significant prognostic marker in oral and oropharyngeal cancer. (14th August 2012) Authors: Perisanidis, C; Savarese‐Brenner, B; Würger, T; Wrba, F; Huynh, A; Schopper, C; Kornek, G; Selzer, E; Ewers, R; Psyrri, A; Krainer, M; Filipits, M Journal: Oral diseases Issue: Volume 19:Number 2(2013:Mar.) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P06.08 Immunomodulatory biomarkers in neoadjuvant chemotherapy of breast cancer. (1st October 2020) Authors: Wimmer, K; Sachet, M; Exner, R; Fitzal, F; Filipits, M; Oehler, R Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2– disease: results from 1204 patients in the randomized ABCSG-8 trial. Issue 3 (20th February 2021) Authors: Fitzal, F; Filipits, M; Fesl, C; Rudas, M; Greil, R; Balic, M; Moinfar, F; Herz, W; Dubsky, P; Bartsch, R; Ferree, S; Schaper, C; Gnant, M Journal: British journal of surgery Issue: Volume 108:Issue 3(2021) Page Start: 308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗